Literature DB >> 17197920

Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms.

Marisa R Nucci1, David Harburger, Jason Koontz, Paola Dal Cin, Jeffrey Sklar.   

Abstract

Nonrandom cytogenetic abnormalities of chromosomes 6, 7, and 17 have been reported within low-grade endometrial stromal sarcomas (LGESSs), and among these abnormalities, the t(7;17)(p15;q21) is the most common aberration described. Previously we had shown that this translocation joins 2 genes, JAZF1 and JJAZ1, located on chromosomes 7 and 17, respectively. To determine the frequency of the t(7;17), we analyzed 4 stromal nodules and 24 LGESS by both reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization (FISH). In addition, we examined 4 cases of highly cellular leiomyoma, a benign morphologic mimic of LGESS. Overall, evidence for the JAZF1-JJAZ1 fusion was found in 60% of endometrial stromal neoplasms analyzed (8/16 ESS and 4/4 stromal nodules). One LGESS demonstrated only rearrangement of 7p15 by FISH analysis and karyotypic analysis of this case showed t(6;7)(p21;p15). The fusion was not detected in any highly cellular leiomyomas. Our data suggest that the JAZF1-JJAZ1 fusion is a frequent, although nonuniform, feature of endometrial stromal neoplasia, irrespective of benign versus malignant classification and smooth muscle differentiation. In addition, the detection of the fusion by reverse transcriptase-polymerase chain reaction or FISH for JJAZ1 at 7p15 may be diagnostically useful.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197920     DOI: 10.1097/01.pas.0000213327.86992.d1

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Authors:  Lien N Hoang; Amandeep Aneja; Niamh Conlon; Deborah F Delair; Sumit Middha; Ryma Benayed; Martee L Hensley; Kay J Park; Travis J Hollmann; Meera R Hameed; Cristina R Antonescu; Robert A Soslow; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

Review 2.  Practical issues related to uterine pathology: endometrial stromal tumors.

Authors:  Marisa R Nucci
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

Review 3.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

Review 4.  Current management of uterine sarcomas.

Authors:  Elena García-Martínez; Lucas Egea Prefasi; Jesús García-Donas; Pedro Pablo Escolar-Pérez; Francisco Pastor; Antonio González-Martín
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

5.  Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination.

Authors:  Katharina Steinmann; David N Cooper; Lan Kluwe; Nadia A Chuzhanova; Cornelia Senger; Eduard Serra; Conxi Lazaro; Montserrat Gilaberte; Katharina Wimmer; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2007-10-31       Impact factor: 11.025

6.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

7.  Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival.

Authors:  Hui Li; Xianyong Ma; Jinglan Wang; Jason Koontz; Marisa Nucci; Jeffrey Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

8.  Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.

Authors:  Cheng-Han Lee; Rola H Ali; Marjan Rouzbahman; Adrian Marino-Enriquez; Meijun Zhu; Xiangqian Guo; Alayne L Brunner; Sarah Chiang; Samuel Leung; Nataliya Nelnyk; David G Huntsman; C Blake Gilks; Torsten O Nielsen; Paola Dal Cin; Matt van de Rijn; Esther Oliva; Jonathan A Fletcher; Marisa R Nucci
Journal:  Am J Surg Pathol       Date:  2012-10       Impact factor: 6.394

Review 9.  Epigenetic Alterations in Bone and Soft Tissue Tumors.

Authors:  John Wojcik; Kumarasen Cooper
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

10.  Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma.

Authors:  Yoshiteru Kakuno; Takashi Yamada; Hiroshi Mori; Isamu Narabayashi
Journal:  Hum Cell       Date:  2008-05       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.